Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Deshpande Milind Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
08/18/2021 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.69, valued at $102.7k
01/06/2021 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 2,629 options to buy @ $17.93, valued at $47.1k
10/27/2020 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.52, valued at $101.4k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2019 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $10.67, valued at $64.8k
06/06/2018 4 Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $11.54, valued at $70.1k
02/13/2018 4 Deshpande Milind (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 640,000 options to buy @ $2.9, valued at $1.9M
11/01/2017 3 Deshpande Milind (Director) has filed a Form 3 on Spero Therapeutics, Inc.
01/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/05/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/22/2016 4 Deshpande Milind (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 400,000 options to buy @ $7.61, valued at $3M
01/23/2015 4 Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 100,000 shares @ $15, valued at $1.5M
Exercised 100,000 options to buy @ $3.02, valued at $302k
12/04/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/19/2014 4 Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 16,250 shares @ $10, valued at $162.5k
Sold 15,950 shares @ $10, valued at $159.5k
Sold 60,000 shares @ $10, valued at $600k
Sold 124,424 shares @ $10, valued at $1.2M
Exercised 16,250 options to buy @ $4, valued at $65k
Exercised 15,950 options to buy @ $1.05, valued at $16.7k
Exercised 60,000 options to buy @ $3.28, valued at $196.8k
Exercised 124,424 options to buy @ $3.1, valued at $385.7k
05/23/2014 4 Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed of 250,000 options to buy @ $3.02, valued at $755k
Granted 250,000 options to buy @ $3.02, valued at $755k
12/19/2013 4 Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 400,000 options to buy @ $3.02, valued at $1.2M
05/30/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/19/2012 4 Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 5,312 shares @ $10.7, valued at $56.8k
Exercised 5,312 options to buy @ $1.05, valued at $5.6k
01/11/2012 4 Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 10,625 shares @ $9.34, valued at $99.2k
Exercised 10,625 options to buy @ $1.05, valued at $11.2k
12/14/2011 4 Deshpande Milind (President of R&D and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 100,000 options to buy @ $7.59, valued at $759k
06/24/2011 4 Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Sold 10,800 shares @ $7.5063, valued at $81.1k
Sold 4,825 shares @ $7.5034, valued at $36.2k
12/20/2010 4 Deshpande Milind (President of R&D and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 200,000 options to buy @ $3.1, valued at $620k
12/22/2009 4 Deshpande Milind (EVP and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 60,000 options to buy @ $3.28, valued at $196.8k
12/17/2008 4 Deshpande Milind (EVP and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy